EMEA-003594-PIP01-24 - paediatric investigation plan
fulzerasib
PIPHuman
Key facts
- Active Substance
- fulzerasib
- Therapeutic area
- Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- Decision number
- P/0231/2024
- PIP number
- EMEA-003594-PIP01-24
- Pharmaceutical form(s)
- All pharmaceutical forms
- Condition(s) / indication(s)
- Treatment of colorectal cancer
- Route(s) of administration
- All routes of administration
- Contact for public enquiries
Zhejiang Genfleet Therapeutics Co. Ltd.
Email: hgrac@genfleet.com
Tel.: +86 57582586890- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date